Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yong-Mei Song
Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
MicroRNA-886-3P Functions as a Tumor Suppressor in Small Cell Lung Cancer
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Related publications
A Nanobody Activation Immunotherapeutic That Selectively Destroys HER2-Positive Breast Cancer Cells
ChemBioChem
Organic Chemistry
Biochemistry
Molecular Medicine
Molecular Biology
Copolymer Micelles Function as pH-responsive Nanocarriers to Enhance the Cytotoxicity of a HER2 Aptamer in HER2-positive Breast Cancer Cells
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Novel Approaches to Target HER2-positive Breast Cancer: Trastuzumab Emtansine
Cancer Management and Research
Oncology
Personalized Drug Combinations to Overcome Trastuzumab Resistance in HER2-positive Breast Cancer
Biochimica et Biophysica Acta - Reviews on Cancer
Cancer Research
Oncology
Genetics
Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer
Oncotarget
Oncology
Targeted Therapy for HER2 Positive Breast Cancer
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer
International Journal of Breast Cancer
Cancer Research
Oncology
Pharmacology
Adjuvant Treatment of HER2-positive Breast Cancer: Winning Efforts Continue to Improve HER2-positive Patient Outcome Long-Term
Breast Cancer Research
Cancer Research
Oncology
Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
Scientific Reports
Multidisciplinary